WXIBF
Price:
$4.04
Market Cap:
$120.47B
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Bioscienc...[Read more]
Industry
Biotechnology
IPO Date
2018-01-30
Stock Exchange
OTC
Ticker
WXIBF
According to WuXi Biologics (Cayman) Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 28.86. This represents a change of 117.73% compared to the average of 13.26 of the last 4 quarters.
The mean historical PE Ratio of WuXi Biologics (Cayman) Inc. over the last ten years is 158.28. The current 28.86 PE Ratio has changed 1.72% with respect to the historical average. Over the past ten years (40 quarters), WXIBF's PE Ratio was at its highest in in the December 2016 quarter at 1.25K. The PE Ratio was at its lowest in in the June 2024 quarter at 7.62.
Average
158.28
Median
106.85
Minimum
20.06
Maximum
602.42
Discovering the peaks and valleys of WuXi Biologics (Cayman) Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 84.66%
Maximum Annual PE Ratio = 602.42
Minimum Annual Increase = -66.26%
Minimum Annual PE Ratio = 20.06
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 20.06 | -37.01% |
| 2023 | 31.85 | -36.16% |
| 2022 | 49.89 | -49.04% |
| 2021 | 97.89 | -54.23% |
| 2020 | 213.87 | 84.66% |
| 2019 | 115.82 | 26.31% |
| 2018 | 91.69 | -41.24% |
| 2017 | 156.05 | -23.21% |
| 2016 | 203.23 | -66.26% |
| 2015 | 602.42 | -1.20% |
The current PE Ratio of WuXi Biologics (Cayman) Inc. (WXIBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
33.93
5-year avg
82.71
10-year avg
158.28
WuXi Biologics (Cayman) Inc.’s PE Ratio is less than Sino Biopharmaceutical Limited (28.91), greater than Genmab A/S (14.78), less than Innovent Biologics, Inc. (125.57), less than Sino Biopharmaceutical Limited (28.91), less than Straumann Holding AG (36.81), less than Astellas Pharma Inc. (44.02), less than bioMérieux S.A. (33.10), less than Straumann Holding AG (36.81), greater than Orion Oyj (22.66), less than Astellas Pharma Inc. (44.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| 28.91 | $16.29B | |
| 14.78 | $19.76B | |
| 125.57 | $20.96B | |
| 28.91 | $15.60B | |
| 36.81 | $18.94B | |
| 44.02 | $22.89B | |
| 33.10 | $15.61B | |
| 36.81 | $18.17B | |
| 22.66 | $19.77B | |
| 44.02 | $21.91B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like WuXi Biologics (Cayman) Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like WuXi Biologics (Cayman) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is WuXi Biologics (Cayman) Inc.'s PE Ratio?
How is the PE Ratio calculated for WuXi Biologics (Cayman) Inc. (WXIBF)?
What is the highest PE Ratio for WuXi Biologics (Cayman) Inc. (WXIBF)?
What is the 3-year average PE Ratio for WuXi Biologics (Cayman) Inc. (WXIBF)?
What is the 5-year average PE Ratio for WuXi Biologics (Cayman) Inc. (WXIBF)?
How does the current PE Ratio for WuXi Biologics (Cayman) Inc. (WXIBF) compare to its historical average?